6076 - 6100 of 6420 Results
Title
Year
-
OPENTitle: Atrophy in the Thalamus But Not Cerebellum Is Specific for C9orf72 FTD and ALS Patients – An Atlas-Based Volumetric MRI StudyJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2018.00045Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2018.00045/pdfCitation Count: 47
-
OPENTitle: Clinical and functional evidence for the pathogenicity of the LRRK2 p.Arg1067Gln variantJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-00884-6Best OA location URL: https://www.nature.com/articles/s41531-025-00884-6.pdfCitation Count: 1
-
OPENTitle: Characterizing expression changes in noncoding RNAs during aging and heterochronic parabiosis across mouse tissuesJournal Name: Nature BiotechnologyPublisher: Springer Science and Business Media LLCVol: 42Issue #: 1Start Page: 109End Page: 118Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41587-023-01751-6Best OA location URL: https://www.nature.com/articles/s41587-023-01751-6.pdfCitation Count: 34
-
OPENTitle: Sex Differences in Brain and Cognition in de novo Parkinson's DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.791532Best OA location URL: https://doi.org/10.3389/fnagi.2021.791532Citation Count: 34
-
OPENTitle: Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-021-00427-6Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-021-00427-6Citation Count: 341
- Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression2020OPENTitle: Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 1999End Page: 2008Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28206Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28206Citation Count: 156
-
OPENTitle: The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptorJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-018-1100-1Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-018-1100-1Citation Count: 148
-
OPENTitle: Melanocortin 1 receptor activation protects against alpha-synuclein pathologies in models of Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s13024-022-00520-4Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-022-00520-4Citation Count: 15
-
OPENTitle: Human plasma biomarker responses to inhalational general anaesthesia without surgeryJournal Name: British Journal of AnaesthesiaPublisher: Elsevier BVVol: 125Issue #: 3Start Page: 282End Page: 290Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bja.2020.04.085Best OA location URL: http://www.bjanaesthesia.org/article/S0007091220303391/pdfCitation Count: 40
- Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects2014OPENTitle: Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjectsJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 571Issue #:Start Page: 34End Page: 38Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2014.04.027Best OA location URL: http://doi.org/10.1016/j.neulet.2014.04.027Citation Count: 130
-
OPENTitle: Poly (ADP-ribose) Interacts With Phosphorylated α-Synuclein in Post Mortem PD SamplesJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page: 704041End Page: 704041Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.704041Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2021.704041/pdfCitation Count: 23
-
OPENTitle: Small molecule C381 targets the lysosome to reduce inflammation and ameliorate disease in models of neurodegenerationJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 119Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2121609119Best OA location URL: https://escholarship.org/uc/item/4pt523rvCitation Count: 40
-
OPENTitle: Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 UpdateJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 13Issue #: 4Start Page: 427End Page: 439Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-239901Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd239901?id=journal-of-parkinsons-disease%2Fjpd239901Citation Count: 62
-
OPENTitle: ATP13A3 is a major component of the enigmatic mammalian polyamine transport systemJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 296Issue #:Start Page: 100182End Page: 100182Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.ra120.013908Best OA location URL: http://www.jbc.org/article/S0021925820001787/pdfCitation Count: 69
-
OPENTitle: Novel Thienopyrimidine-Based PET Tracers for P2Y12 Receptor Imaging in the BrainJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 12Issue #: 23Start Page: 4465End Page: 4474Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acschemneuro.1c00641Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8640995Citation Count: 26
- Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's disease2019OPENTitle: Longitudinal analyses of cerebrospinal fluid α‐Synuclein in prodromal and early Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 9Start Page: 1354End Page: 1364Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27806Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27806Citation Count: 110
-
OPENTitle: DeepSleep convolutional neural network allows accurate and fast detection of sleep arousalJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s42003-020-01542-8Best OA location URL: https://www.nature.com/articles/s42003-020-01542-8.pdfCitation Count: 39
-
OPENTitle: Predicting Progression in Parkinson’s Disease Using Baseline and 1-Year Change MeasuresJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 9Issue #: 4Start Page: 665End Page: 679Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-181518Best OA location URL: https://escholarship.org/uc/item/2w68g45qCitation Count: 20
-
OPENTitle: Neuromelanin accumulation drives endogenous synucleinopathy in non-human primatesJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 12Start Page: 5000End Page: 5014Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/brain/awad331Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awad331/51792215/awad331.pdfCitation Count: 16
-
OPENTitle: Guanabenz promotes neuronal survival via enhancement of ATF4 and parkin expression in models of Parkinson diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 303Issue #:Start Page: 95End Page: 107Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2018.01.015Citation Count: 39
-
OPENTitle: The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseasesJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-023-42305-3Best OA location URL: https://www.nature.com/articles/s41467-023-42305-3.pdfCitation Count: 64
-
OPENTitle: GP2: The Global Parkinson's Genetics ProgramJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 4Start Page: 842End Page: 851Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.28494Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28494Citation Count: 129
-
OPENTitle: Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson’s Disease in RodentsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 8Issue #: 2Start Page: 303End Page: 322Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-171248Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd171248?id=journal-of-parkinsons-disease%2Fjpd171248Citation Count: 234
-
OPENTitle: The Remote Assessment of Parkinsonism Supporting the Ongoing Development of Interventions in Gaucher DiseaseJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol: 11Issue #: 6Start Page: 451End Page: 458Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.2217/nmt-2021-0032Best OA location URL: https://doi.org/10.2217/nmt-2021-0032Citation Count: 14
-
OPENTitle: Pedunculopontine Nucleus Dysconnectivity Correlates With Gait Impairment in Parkinson’s Disease: An Exploratory StudyJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.874692Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.874692/pdfCitation Count: 7